...
首页> 外文期刊>Forensic science international >Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
【24h】

Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.

机译:在药物影响下驾驶-评估口服液,血清和尿液中药物的分析数据,以及与损伤症状的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

A study was performed to acquire urine, serum and oral fluid samples in cases of suspected driving under the influence of drugs of abuse. Oral fluid was collected using a novel sampling/testing device (Drager DrugTest((R)) System). The aim of the study was to evaluate oral fluid and urine as a predictor of blood samples positive for drugs and impairment symptoms. Analysis for cannabinoids, amphetamine and its derivatives, opiates and cocaine was performed in urine using the Mahsan Kombi/DOA4-test, in serum using immunoassay and gas chromatography-mass spectrometry (GC-MS) confirmation and in oral fluid by GC-MS. Police and medical officer observations of impairment symptoms were rated and evaluated using a threshold value for the classification of driving inability. Accuracy in correlating drug detection in oral fluid and serum were >90% for all substances and also >90% in urine and serum except for THC (71.0%). Of the cases with oral fluid positive for any drug 97.1% of corresponding serum samples were also positive for at least one drug; of drug-positive urine samples this were only 82.4%. In 119 of 146 cases, impairment symptoms above threshold were observed (81.5%). Of the cases with drugs detected in serum, 19.1% appeared not impaired which were the same with drug-positive oral fluid while more persons with drug-positive urine samples appeared uninfluenced (32.7%). The data demonstrate that oral fluid is superior to urine in correlating with serum analytical data and impairment symptoms of drivers under the influence of drugs of abuse.
机译:进行了一项研究,以在滥用药物的影响下怀疑驾驶的情况下采集尿液,血清和口腔液体样品。使用新型采样/测试装置(Drager DrugTest系统)收集口腔液。该研究的目的是评估口服液和尿液,以预测药物和损伤症状阳性的血样。使用Mahsan Kombi / DOA4-test对尿液中的大麻素,苯丙胺及其衍生物,鸦片剂和可卡因进行分析,使用免疫测定法和气相色谱-质谱法(GC-MS)确证在血清中进行分析,并通过GC-MS对口腔液进行分析。警察和医务人员对障碍症状的观察结果被评估,并使用阈值对驾驶不便进行分类。除四氢大麻酚(71.0%)外,所有物质在口服液和血清中相关药物检测的准确性均> 90%,在尿液和血清中也> 90%。在任何一种药物的口服液阳性的病例中,相应的血清样本中97.1%的至少一种药物也呈阳性。在药物阳性尿液样本中,这一比例仅为82.4%。 146例病例中有119例观察到损伤症状超过阈值(81.5%)。在血清中检测到药物的病例中,有19.1%的人似乎没有受损,这与药物阳性的口服液相同,而更多的具有药物阳性的尿液样本的人似乎没有受到影响(32.7%)。数据表明,在滥用药物的影响下,口服液优于尿液与血清分析数据和驾驶员损伤症状相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号